Australia markets open in 32 minutes

Next Science Limited (NXS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.6650-0.0200 (-2.92%)
At close: 04:10PM AEDT

Next Science Limited

The Zenith Building, Tower A
Suite 1902 Level 19 821 Pacific Highway
Chatswood, NSW 2067
Australia
61 2 8607 5126
https://www.nextscience.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full-time employees

Key executives

NameTitlePayExercisedYear born
Ms. Judith Mitchell M.B.A.MD, CEO & Exec. Director288.08kN/AN/A
Dr. Matthew Franco MynttiFounder & CTO366.61kN/AN/A
Ms. Jacqueline Butler CA (ICAEW)Chief Financial Officer267.91kN/AN/A
Mr. Jon SwansonChief Operating Officer265.18kN/AN/A
Mr. Martyn JacobsHead of Investor RelationsN/AN/AN/A
Ms. Gillian Maria Nairn AGIA, B.A., BA, L.L.B., L.L.M., LLB, LLM, MAICDCompany Sec.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.

Corporate governance

Next Science Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.